InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Monday, 09/22/2014 12:19:59 AM

Monday, September 22, 2014 12:19:59 AM

Post# of 345746
Bavituximab Docetaxel Phase III SunRise Non Small Cell Lung Cancer

For the first time, at least in my searches, I did a search for only "Bavituximab" and now on the very first first page of results you see "CenterWatch" and gives a very nice listing of full trial sites

The search
https://www.google.com/?gws_rd=ssl#q=bavituximab&tbs=qdr:w

Centerwatch link:
http://www.centerwatch.com/clinical-trials/listings/ctrc/condition/683/non-small-cell-lung-cancer?mp=amf

-----------------------------------------------------------

notice below at bottom right corner, the "updates" section says 9/17/2014, so one can assume centerwatch gets all this info from clinicaltrials.gov ??... because clinical trials.gov was also updated last on 9/17

http://www.centerwatch.com/clinical-trials/listings/external-studydetails-ctrc.aspx?StudyID=NCT01999673&CatID=683&mp=amf

http://clinicaltrials.gov/ct2/show/NCT01999673?term=bavituximab&rank=3

--------------------------------------------------------

Now the interesting part, which I believe was discussed before:

All those "updated" highlighted links next to all 138 sites do say "updated".. right? and my first thought was it was updated because sites were added, since I'm so used to sites being added almost on a weekly basis, but what was really updated on 9/17/2014 ?? I don't think that was ever made final, as we only seen a "DATE CHANGE"

Either way... it shows a change, and now those Bavi trials stand out more, so if it was truly just a date change, keep updating the date every week or so since it does allow the Bavituximab/Docetaxel to stand out

... unless it was modified/changed to allow for some blood test of some sort, that is not visible to the general public??

just like there is an exception for hedge funds to conceal certain stocks they buy with permission from the SEC (up to one year), all based on protecting their intent/goal to accumulate shares, maybe the FDA allows for some type of hidden modifier, to protect Peregrines intent/goal surrounding "SunRise" Phase III

everything is possible

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News